CHARGE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, April 22, 2025, a trademark application was filed for CHARGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CHARGE THERAPEUTICS trademark a serial number of 99148525. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, October 23, 2025. This trademark is owned by STEALTH BIOTHERAPEUTICS INC.. The CHARGE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific research and development; biopharmaceutical research, development and testing; Medical and scientific research in the field of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic systems

Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities
charge therapeutics

General Information


Serial Number99148525
Word MarkCHARGE THERAPEUTICS
Filing DateTuesday, April 22, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, October 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesScientific research and development; biopharmaceutical research, development and testing; Medical and scientific research in the field of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic systems
Goods and ServicesBiopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 22, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSTEALTH BIOTHERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNeedham, MA 02494

Trademark Events


Event DateEvent Description
Tuesday, April 22, 2025NEW APPLICATION ENTERED
Tuesday, April 22, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 15, 2025ASSIGNED TO EXAMINER
Monday, September 22, 2025NON-FINAL ACTION WRITTEN
Monday, September 22, 2025NON-FINAL ACTION E-MAILED
Monday, September 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, October 23, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, October 23, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 23, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, October 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER